Completed NA INTERVENTIONAL NCT01414868

Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA)

Could Leukotriene D4 Bronchial Provocation Test be a Clear Indicator for Predicting Therapeutic Outcomes of Leukotriene Receptor Antagonist A Pilot Study

Sponsor: Guangzhou Institute of Respiratory Disease

Conditions Bronchial Asthma

Interventions leukotriene receptor antagonist (montelukast)

Updated 5 times since 2017 Last updated: Aug 17, 2011 Started: Mar 31, 2010 Primary completion: Sep 30, 2010 Completion: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01414868, this NA trial focuses on Bronchial Asthma and remains completed. Sponsored by Guangzhou Institute of Respiratory Disease, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangzhou Institute of Respiratory Disease

Data source: Guangzhou Institute of Respiratory Disease

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China